For many decades, tools for cell-cell communication were of great concern in various research fields, not only in basic research, but also in medical research. Although a large number of humoral factors, such as cytokines, chemokines, growth factors, hormones, and so on, have been identified and characterized, few molecular mechanisms of cell-cell communication have been clarified. Recently, small membrane vesicles, called exosomes (also known as extracellular vesicles), have been at the center of attention again. Current vigorous worldwide research found that exosomes play multiple important roles in physiological and pathological phenomena. In this review, we will summarize our current reports showing the essential roles of exosomes in cancer development, the novel utility of exosomes to know the status of the patient, and the potential novel treatment choice for neurological disease.
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Mini Review Exosome in disease treatment are secreted from cells. One of that, microvesicles, also known as microparticles or shedding vesicles, represent a heterogeneous population of vesicles with a diameter of 100 to 1000 nm that are released by budding of the plasma membrane 11) , although there are few report showing their function in cell-cell communication compared with exosome.
In this review, we will briefly summarize our current findings about the roles of exosomes in cancer development 12, 13) .
In addition, we will also introduce our current reports about the usage of exosomes for diagnostic 14) and therapeutic 15) purposes. Finally, we will discuss the future direction of exosome usage in medical situations.
Biological meaning of exosomes in cancer
Exosomes, also known as extracellular vesicles, are 20-to 200-nm vesicles secreted from living cells 16, 17) , and they contain various types of proteins, RNAs 18) (mRNA, noncoding RNA, and microRNAs (miRNAs)), and in some cases, DNA 19, 20) . Exosomes are positive for tetraspanin family proteins, such as CD63, CD81, and CD9 17, 21, 22) , and . This conclusion is supported by other groups.
For instance, exosomes from melanoma cells mediated the conditioning of lymph nodes and defined microanatomic responses that license the metastasis of melanoma cells 26) .
In addition, exosomes from melanoma cells increased the metastatic behavior of primary tumors by permanently "educating" bone marrow progenitors through the receptor tyrosine kinase MET 27) .
Recently, we found a novel exosome-mediated phenomenon in cancer recurrence 12) . Cancer recurrence often occurs, and this is a serious problem for cancer cure. . We currently found that exosomes from bone marrow-derived mesenchymal stem cells (MSCs) can be transferred to the bone marrow-metastatic human breast cancer cell line, and it caused the bone marrow-metastatic human breast cancer cell line to be dormant phenotypes. Interestingly, we also clarified that miRNA in exosomes from bone marrowderived MSCs suppresses the expression of MARCKS, which encodes a protein that promotes cell cycling and motility, in the bone marrow-metastatic human breast cancer cell line.
Currently, it is known that exosomes secreted by cancer cells play an important role in cancer progression by promoting angiogenesis 19) , neutrophil infiltration 29) , and the education of bone marrow-derived cells 27) . Thus it is an 
Exosomes in body fluid can be used to monitor human status
In addition to the roles of exosomes reported by our group and other groups, exosomes contribute much toward pathological phenomena, including cancer, immunological disease 30, 31) , neurological disease 32) , and so on. From this point of view, it is natural to think that exosomes can be used to detect these kinds of diseases as well as for diagnosis or trace markers. Indeed, it has been reported that circulating exosomes in cancer patients increased along with the stage of cancer 33, 34) . In addition, the expressions of proteins on the surface of the exosome are higher in an advanced stage of cancer than in non-malignant cancer 27) .
Although there is much evidence showing the existence of exosomes in human body fluids, and this fact will have an outstanding impact against future personal medicine, detecting the exosome in human body fluid remains one of many consuming issues to be solved. One of the most serious problems is that we don't have superior techniques to isolate exosomes with a small amount of human body fluid, and this makes the detection method very difficult.
Detecting exosomes by a novel developing method
As In our laboratory, to realize the usage of exosomes in a clinical situation, we established a highly sensitive and rapid analytical technique for profiling surface proteins in exosomes from human body fluids without an exosome purification step 14) . This method is simple to use, meaning that many researchers can easily use our techniques without any barriers. The novel screening system we developed, called ExoScreen, is based on an amplified luminescent proximity homogeneous assay using photosensitizer 35) . Streptavidin-coated donor beads, which capture an analyte-specific biotinylated antibody, and acceptor beads conjugated to a second antibody, which recognizes an epitope of the analyte, were used. antigens on exosomes; thus, it is essential to identify the cancer-specific or disease-specific exosome in human body fluid. The current organization of the exosome database might be helpful for this 38) .
Exosomes as a novel therapeutic tool to cure neurological disease
As shown above, the exosome itself has a variety of functions to mediate the communication between cells. In other words, if we use these exosome functions, we can send the "correcting message" to recipient cells, such as insufficient molecules in sick recipient cells. For instance,
we recently revealed that exosome-harbored neprilysin (neutral endopeptidase: NEP) can decrease the β-amyloid peptide whose accumulation is thought to be one cause of Alzheimer's disease (AD) 15) . NEP is a type II membraneassociated metalloendopeptidase, and it appears to be the most important among several proteases involved in the proteolysis of Aβ 39, 40) , because decreased expression and activity of NEP in AD patients were reported 41) . We know that the expression of neprilysin in adipose tissue-derived MSCs (ADSCs) is higher than that in bone marrow-derived 
Conclusion and future perspectives
In this review, we summarize our recent progress in the basic research and medical research in human disease. and we can use exosomes to treat the disease. These facts appear promising for future personal medicine; however, there are still issues to be resolved for medical usage.
Below, we summarize the recent issues to be solved: Much of the research has been done in the past several years; however, we need to continue in order to understand exosome function and character in more detail. Then we can freely use exosomes in clinical situation (Fig. 1) . These exosome can be used not only for cancer treatment but also for disease treatment based on the character of exosome, such as Alzheimer disease (3).
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